• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Health & Medicine

Hormone therapy now available for newly diagnosed prostate cancer in Scotland 

A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.   A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.  

20 January 2020

• Health & Medicine

New breed of targeted cancer drug gets initial ‘no’ for NHS in England  

A targeted drug, larotrectinib (Vitrakvi), will not be made an option for adults and children whose tumours test positive for a specific genetic change. A targeted drug, larotrectinib (Vitrakvi), will not be made an option for adults and children whose tumours test positive for a specific genetic change.

15 January 2020

• Health & Medicine

Targeted ovarian cancer drug made more widely available on the NHS in Scotland

A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy. A targeted cancer drug has been approved for use on the NHS in Scotland for patients with newly diagnosed ovarian cancer that’s responded to chemotherapy.

9 December 2019

• Health & Medicine

Targeted breast cancer treatment approved for NHS use in England

A new treatment for early stage breast cancer will be made available for certain patients on the NHS in England. A new treatment for early stage breast cancer will be made available for certain patients on the NHS in England.

17 October 2019

• Health & Medicine

Advanced ovarian cancer drug gets initial ‘no’ for NHS in England

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England. A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

9 August 2019

• Health & Medicine

Ovarian cancer drug will be offered earlier to NHS patients in England

A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England. A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.

26 July 2019

• Health & Medicine

One lung cancer drug receives NHS England approval, while another is rejected

A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer.

5 July 2019

• Health & Medicine

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy. A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

2 June 2019

• Health & Medicine

Precision drug combo boosts survival in younger women with advanced breast cancer

Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial. Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.

1 June 2019

• Health & Medicine

Skin and breast cancer drugs approved for NHS use in Scotland

An immunotherapy for some patients with advanced skin cancer and a targeted drug for some women with breast cancer have been approved for NHS Scotland. An immunotherapy for some patients with advanced skin cancer and a targeted drug for some women with breast cancer have been approved for NHS Scotland.

16 May 2019

• Health & Medicine

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer. Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

17 April 2019